14.05
-0.25 (-1.75%)
| Previous Close | 14.30 |
| Open | 14.42 |
| Volume | 1,542,222 |
| Avg. Volume (3M) | 1,813,495 |
| Market Cap | 638,538,816 |
| Price / Earnings (Forward) | 86.96 |
| Price / Sales | 2.70 |
| 52 Weeks Range | |
| Earnings Date | 5 Aug 2025 - 11 Aug 2025 |
| Profit Margin | -4.59% |
| Operating Margin (TTM) | 3.87% |
| Diluted EPS (TTM) | -0.330 |
| Quarterly Revenue Growth (YOY) | 48.80% |
| Current Ratio (MRQ) | 0.820 |
| Operating Cash Flow (TTM) | 15.38 M |
| Levered Free Cash Flow (TTM) | 6.75 M |
| Return on Assets (TTM) | -6.88% |
| Return on Equity (TTM) | -2,243.07% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Health Information Services (US) | Bearish | Mixed |
| Health Information Services (Global) | Bearish | Mixed | |
| Stock | LifeMD, Inc. | Mixed | Bullish |
AIStockmoo Score
| Analyst Consensus | -3.5 |
| Insider Activity | -5.0 |
| Price Volatility | -3.0 |
| Technical Moving Averages | 0.0 |
| Technical Oscillators | 4.0 |
| Average | -1.50 |
|
LifeMD Inc is a direct-to-patient telehealth company that provides a smarter, cost-effective, and more convenient way of accessing comprehensive, virtual healthcare. Its telehealth platform seamlessly integrates a clinician-centric electronic medical record (EMR) system, proprietary algorithms for case-load balancing and scheduling, customer relationship management functionality, remote and in-home lab testing, and digital prescription capabilities, patient-provider audio/video interfacing, cloud pharmacy fulfillment, and more. In addition to telehealth offerings, the company sells nutritional supplements and other over-the-counter products. The company has two operating segments: Telehealth and WorkSimpli. The company generates the majority of its revenue from the Telehealth segment. |
|
| Sector | Healthcare |
| Industry | Health Information Services |
| Investment Style | Small Core |
| % Held by Insiders | 15.99% |
| % Held by Institutions | 37.46% |
| 52 Weeks Range | ||
| Median | 14.00 (-0.36%) | |
| Total | 1 Buy | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| HC Wainwright & Co. | 30 Apr 2025 | 14.00 (-0.36%) | Buy | 7.36 |
| Name | Avg. Buy ($) | Avg. Sell ($) | Net Quantity | Net Value ($) |
|---|---|---|---|---|
| BENATHEN MARC DAVID | - | 13.53 | -125,000 | -1,689,250 |
| Aggregate Net Quantity | -125,000 | |||
| Aggregate Net Value ($) | -1,689,250 | |||
| Aggregate Avg. Buy ($) | - | |||
| Aggregate Avg. Sell ($) | 13.53 | |||
| Name | Holder | Date | Type | Quantity | Price | Value ($) |
|---|---|---|---|---|---|---|
| BENATHEN MARC DAVID | Officer | 17 Jun 2025 | Sell (-) | 50,000 | 13.58 | 679,000 |
| BENATHEN MARC DAVID | Officer | 16 Jun 2025 | Sell (-) | 75,000 | 13.47 | 1,010,250 |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |